These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8941578)

  • 1. Long-term outcome of adult-onset minimal-change nephropathy.
    Mak SK; Short CD; Mallick NP
    Nephrol Dial Transplant; 1996 Nov; 11(11):2192-201. PubMed ID: 8941578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.
    Szeto CC; Lai FM; Chow KM; Kwan BC; Kwong VW; Leung CB; Li PK
    Am J Kidney Dis; 2015 May; 65(5):710-8. PubMed ID: 25465164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal-change glomerulopathy of adulthood.
    Korbet SM; Schwartz MM; Lewis EJ
    Am J Nephrol; 1988; 8(4):291-7. PubMed ID: 3189423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
    Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
    Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
    Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
    Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.
    Tse KC; Lam MF; Yip PS; Li FK; Choy BY; Lai KN; Chan TM
    Nephrol Dial Transplant; 2003 Jul; 18(7):1316-20. PubMed ID: 12808168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-onset minimal change nephrotic syndrome: a long-term follow-up.
    Nolasco F; Cameron JS; Heywood EF; Hicks J; Ogg C; Williams DG
    Kidney Int; 1986 Jun; 29(6):1215-23. PubMed ID: 3747335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of adult-onset minimal change nephrotic syndrome in our hospital].
    Mori D; Shinzawa M; Namba T; Yamaguchi Y; Itano S; Imakita N; Matsuda J; Murata H; Takeji M; Yamamoto R; Isaka Y; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2012; 54(7):1023-30. PubMed ID: 23234214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with cyclophosphamide in elderly-onset nephrotic syndrome.
    Mak SK; Lo KY; Wong CY; Tong GM; Wong PN; Wong AK
    Nephron Clin Pract; 2005; 101(1):c25-32. PubMed ID: 15886494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
    J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult-onset minimal change disease among Taiwanese: clinical features, therapeutic response, and prognosis.
    Huang JJ; Hsu SC; Chen FF; Sung JM; Tseng CC; Wang MC
    Am J Nephrol; 2001; 21(1):28-34. PubMed ID: 11275629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal function in subjects with minimal change steroid-responsive nephrotic syndrome in childhood].
    Strzelecka-Lichota A
    Ann Acad Med Stetin; 2004; 50(2):41-9. PubMed ID: 16529164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
    Kashtan C; Melvin T; Kim Y
    Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
    Zhou J; Zhang Y; Liu G; Li J; Xu R; Huang J
    Clin Nephrol; 2013 Aug; 80(2):121-9. PubMed ID: 23458173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
    Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
    Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.